Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 10, Issue 4, 2007, Pages 235-257

  Roy, Deodutta ^a   Cai, Qiuyin ^b   Felty, Quentin ^a   Narayan, Satya ^c  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 ISOENZYME; CYTOKINE; DNA; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTRONE; ETHINYLESTRADIOL; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; OXIDIZING AGENT; PENTOXIFYLLINE; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; B LYMPHOCYTE; BREAST CARCINOMA; CANCER MODEL; CELL ACTIVATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; DNA ADDUCT; DNA DAMAGE; DNA MODIFICATION; ESTROGEN METABOLISM; ESTROGEN RESPONSIVE ELEMENT; EXPERIMENTAL MODEL; GENE MUTATION; GENE OVEREXPRESSION; GENOME ANALYSIS; GENOTOXICITY; HORMONAL REGULATION; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MITOCHONDRIAL RESPIRATION; MOLECULAR CLONING; MOLECULAR STABILITY; MONOCYTE; MUTATIONAL ANALYSIS; NITROSATIVE STRESS; NONHUMAN; OVARY CARCINOMA; OXIDATIVE STRESS; PREGNANCY; PROSTATE CARCINOMA; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TESTIS CARCINOMA; UTERUS CARCINOMA;

APOPTOSIS; CYTOKINES; DNA DAMAGE; ESTROGENS; HUMANS; MUTATION; NEOPLASMS, HORMONE-DEPENDENT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 34447335052     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/15287390600974924     Document Type: Review

References (191)

1. Ahmed, S. A., Hissong, B. D., Verthelyi, D., Donner, K., Becker, K., and Karpuzoglu-Sahin, E. 1999. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect. 107(S5):681-686.
2. Akoum, A., Jolicoeur, C., and Boucher, A. 2000. Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis. Clin. Endocrinol. Metab. 85:896-904.
3. Arai, Y., Mori, T., Suzuki, Y., and Bern, H. A. 1983. Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. Int. Rev. Cytol. 84:235-268.
4. Bacon, R. L., and Kirkman, H. 1955. The response of the testis of the hamster to chronic treatment with different estrogens. Endocrinology 57:255-271.
5. Bain, B. J., and England, J. M. 1975. Variations in leukocyte count during menstrual cycle. Br. Med. J. 2:473-475.
6. Banerjee, S. K. and Roy, D. 1996. Is exposure of cells to environmental estrogen-like chemicals able to induce telomeric associations. Proc. Am. Assoc. Cancer Res. 37:547.
7. Banerjee, S. K., Banerjee, S., Li, S. A., and Li, J. J. 1994. Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogen. Mutat. Res. 311:191-197.
8. Baranao, R. I., Tenenbaum, A., Sales, M. E., and Rumi, L. S. 1992. Functional alterations of murine peritoneal macrophages during pregnancy. Am. J. Reprod. Immunol. 27:82-86.
9. Bhan, A. K., and DesMarais, C. L. 1983. Immunohistologic characterization of major histocompatability antigens and inflammatory cellular infiltrate in human breast cancer. JNCI 71:507-516.
10. Bekesi, G., Magyar, Z., Kakucs, R., Sprintz, D., Kocsis, I., Szekacs, B., and Feher, J. 1999. Changes in the myeloperoxidase activity of human neutrophilic granulocytes and the amount of enzyme deriving from them under the effect of estrogen. Orv. Hetil. 140:1625-1630.
11. Bekesi, G., Kakucs, R., Varbiro, S., Feher, J., Pazmany, T., Magyar, Z., Sprintz, D., and Szekacs, B. 2001. Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. British Journal of Obstetrics and Gynaecology 108:474-481.
12. Boorman, G. A., Luster, M. I., Dean, J. H., and Wilson, R. E. 1980. The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J. Reticuloendothel. Soc. 28:547-560.
13. Bosland, M. C. 1996. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. In Cellular and molecular mechanisms of hormonal carcinogenesis: Environmental influences, eds. J. Huff, J. Boyd, and J. C. Barrett, pp. 309-352. New York: Wiley-Liss.
14. Burcham, P. C. 1999. Internal hazards: Baseline DNA damage by endogenous products of normal metabolism. Mutat. Res. 443:11-36.
15. Burdon, R. H. 1997. Oxyradicals as signal transducers. In Oxidative stress and signal transduction, eds. H. J, Forman and E. Cadenas, pp. 289-322. New York: Chapman & Hill.
16. Cannon, J. G., and Danarello, C. A. 1985. Increased plasma interleukin-1 activity in women after ovulation. Science 227:1247-1249.
17. Cannon, J. G., and St. Pierre, B. A. 1997. Gender differences in host defense mechanisms. J. Psychiat. Res. 31:99-113.
18. Cavalieri, E., Frenkel, K., Liehr, J. G., Rogan, E., and Roy, D. 2000. Estrogens as endogenous genotoxic agents- DNA adducts and mutations. JNCI Monogr. 27:75-94.
19. Chakravarti, D., Mailander, P. C., Li, K. M., Higginbotham, S., Zhang, H. L., Gross, M. L., Meza, J. L., Cavalieri, E. L., and Rogan, E. G. 2001. Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene 20:7945-7953.
20. Chang, M., Zhang, F., Shen, L., Pauss, N., Alam, I., van Breemen, R. B., Blond, S. Y., and Bolton, J. L. 1998. Inhibition of glutathione S-transferase activity by the quinoid metabolites of equine estrogens. Chem. Res. Toxicol. 11:758-765.
21. Chen, C. W., and Roy, D. 1993. Attenuation of diethylstilbestrol metabolism by thiol. Proc. Am. Assoc. Cancer Res. 34:157.
22. Chen, J. Q., and Yager, J. D. 2004. Estrogen's effects on mitochondrial gene expression: Mechanisms and potential contributions to estrogen carcinogenesis. Ann. NY Acad. Sci. 1028:258-272.
23. Cohen, J. H., Danel, L., Cordier, G., Saez, S., and Revillard, J. P. 1983. Sex steroid receptors in peripheral T cells: Absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J. Immunol. 131:2767-2771.
24. Cramer, D. W., Harlow, B. L., Titus-Ernstoff, L., Bohlke, K., Welch, W. R., and Greenberg, E. R. 1998. Over-the-counter analgesics and risk of ovarian cancer. Lancet 351:104-107.
25. Crouch, S. P. M., Crocker, I. P., and Fletcher, J. 1995. The effect of pregnancy on polymorphonuclear leukocyte function. J. Immunol. 155:5436-5443.
26. Cutolo, M. 1999. Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic diseases. Ann. NY Acad. Sci. 876:32-42.
27. De, M., and Wood, G. W. 1990. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus. J. Endocrinol. 126:417-424.
28. De Marzo, A. M., Coffey, D. S., and Nelson, W. G. 1999. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 53(suppl. 3A):29-42.
29. D'Agostino, P., Milano, S., Barbera, C., Di Bella, G., La Rosa, M., Ferlazzo, V., Farruggio, R., Miceli, D. M., Miele, M., Castagnetta, L., and Cillari E. 1999. Sex hormones modulate inflammatory mediators produced by macrophages. Ann. NY Acad. Sci. 876:426-429.
30. Delaney, C. A., Pavlovic, D., Hoorens, A., Pipeleers, D. G., and Eizirik, D. L. 1997. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614.
31. Devanesan, P., Santen, R. J., Bocchinfuso, W. P., Korach, K. S., Rogan, E. G., and Cavalieri E. 2001. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: Implications for initiation of mammary tumors. Carcinogenesis 22:1573-1576.
32. Duran, M., Galvez, G. G., de Frutos, T., Diaz-Recasens, J., Casado, S., and Lopez-Farre, A. 2000. 17-Beta-estradiol-stimulated nitric oxide production by neutrophils: Effect on platelet activation. Obstet. Gynecol. 95:284-290.
33. Embrechts, J., Lemiere, F., Van Dongen, W., Esmans, E. L., Buytaert, P., Van Marck, E., Kockx, M., Makar, A. 2003. Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 14:482-491.
34. Endo, S., Kodama, S., Newbold, R., McLachlan, J., and Barrett, J. C. 1994. Cytogenetic analysis of murine cell lines from diethylstilbestrol-induced uterine endometrial adenocarcinomas. Cancer Genet Cytogenet. 74:99-103.
35. Farrar, M. A., and Schreiber, R. D. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
36. Fawcett, D. W., Neaves, W. B., and Flores, M. N. 1973. Comparative observations on intertubular lymphatics and the organization of the interstitial tissue of the mammalian testis. Biol. Reprod. 9:500-532.
37. Feigelson, H. S., and Henderson, B. E. 1996. Estrogens and breast cancer. Carcinogenesis 17:2279-2284.
38. Felty Q., and Roy, D. 2004. Mitochondrial signals to nucleus regulate estrogen-induced cell growth. Med. Hypoth. 64:133-141.
39. Felty, Q., and Roy, D. 2005. Estrogen, mitochondria, and growth of cancer and non-cancer cells. J. Carcinogen. 4:1-25.
40. Felty, Q., Xiong, W. C., Sun, D., Sarkar, S., Singh, K. P., Parkash, J., and Roy, D. 2005a. Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 44:6900-6909.
41. Felty, Q., Singh, K. P., and Roy, D. 2005b. Estrogen-induced G(1)/S transition of G(0)-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 24:4883-4893.
42. Ferry, J. A., Srigley, J. R. and Young, R. H. 1997. Granulocytic sarcoma of the testis: a report of two cases of a neoplasm prone to misinterpretation. Mod. Pathol. 10:320-325.
43. Fox, H. S., Bond, B. L., and Parslow, T. G. 1991. Estrogen regulates the INF-gamma promoter. J. Immunol. 146:4362-4367.
44. Frenkel, K., Wei, H., Bhimani, R., Ye, J., Zadunaisky, J. A., Huang, M. T., Ferraro, T., Conney, A. H., and Grunberger, D. 1993. Inhibition of tumor promoter mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res. 53:2298-2303.
45. Garcia-Duran, M., de Frutos, T., Diaz-Recasens, J., Garcia-Galvez, G., Jimenez. A., Monton, M., Farre, J., Sanchez de Miguel, L., Gonzalez-Fernandez, F., Arriero, M. D., Rico, L., Garcia, R., Casado, S., and Lopez-Farre, A. 1999. Estrogen stimulates neutrophil nitric oxide synthase protein expression in human neutrophils. Circ. Res. 85:1020-1026.
46. Gasson, J. C. 1991. Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131-1145.
47. Gilmore, W., Weiner, L. P., and Correale, J. 1997. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158:446-451.
48. Girasole, G., Jilka, R. L., Passeri, G., Boswell, S., Boder, G., Williams, D. C., and Manolagas, S. C. 1992. 17 Beta-estradiol inhibits interleukin-6 production by born marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antioesteoporotic effect of estrogens. J. Clin. Invest. 89:883-891.
49. Gottlinger, H. G., Rieber, P., Gokel, J. M., Lohe, K. J., and Riethmuller, G. 1985. Infiltrating mononuclear cells in human breast carcinoma: Predominance of T4+ monocytic cells in the tumor stroma. Int. J. Cancer 35:199-205.
50. Greenwald, P., Caputo, T. A., and Wolfgang, P. E. 1977. Endometrial cancer after menopausal use of estrogens. Obstet. Gynecol. 50:239-243.
51. Hanna, I. H., Dawling, S., Roodi, N., Guengerich, F. P., and Parl, F. F. 2000. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60:3440-3444.
52. Harris, M. T., Feldberg, R. S., Lau, K. M., Lazarus, N. H., and Cochrane, D. E. 2000. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate 44:19-25.
53. Haskill, S., Becker, S., Fowler, W., and Walton, L. 1982. Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br. J. Cancer 45:728-736.
54. Head, J. R., and Billingham, R. E. 1985. Immune privilege in the testis. II. Evaluation of potential local factors. Transplantation 40:269-275.
55. Head, J. R., Neaves, W. B., and Billingham, R. E. 1983. Immune privilege in the testis. I. Basic parameters of allograft survival. Transplantation 36:426-431.
56. Hedger, M. P. 1987. Immunology of the testis and sperm. In Reproductive and endocrine toxicology, eds. K. Boekelheide, R. E. Chapin, P. B. Hoyer, and C. Harris, pp. 203-215. New York: Elsevier Science.
57. Hedger, M. P., Khatab, S., Gonzales, G., and de Kretser D. M. 1995. Acute and short-term actions of serotonin administration on the pituitary-testicular axis in the adult rat. Reprod. Fertil. Dev. 7:1101-1109.
58. Hem, E., Attramadal, A., and Tveter, K. J. 1988. Synchronous bilateral primary germ cell tumors in patient receiving estrogen therapy. Urology 31:70-71.
59. Henderson, B. E., and Feigelson, H. S. 2000. Hormonal carcinogenesis. Carcinogenesis 21:427-433.
60. Hendry, W. J. 3rd, Zheng, X., Leavitt, W. W., Branham, W. S., and Sheehan, D. M. 1997. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted uteri. Cancer Res. 57:1903-1908.
61. Hodgson, A. V., Ayala-Torres, S., Thompson, E. B., and Liehr, J. G. 1998. Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis. Carcinogenesis 19:2169-2172.
62. Hoosein, N. M. 1998. Neuroendocrine and immune mediators in prostate cancer progression. Front. Biosci. 15(3D):1274-1279.
63. Hu, S. K., Mitcho, Y. L., and Rath, N. C. 1988. Effect of estradiol on interleukin 1 synthesis by macrophages. Int. J. Immunopharmacol. 10:247-252.
64. Hutson, J. C. 1990. Changes in the concentration and size of testicular macrophages during development. Biol. Reprod. 43:885-890.
65. IARC. 1979. Sex hormones. IARC Monogr. 21:139-343.
66. IARC. 1999. Hormonal contraception and postmenopausal hormonal therapy. IARC Monogr. 72:399-530.
67. Jackson, H., Gajewski, E., Schraufstatter, I. U., Hyslop, P. A., Fuciarelli, A. F., Cochrane, C. G., and Dizdaroglu, M. 1989. Damage to the bases in DNA induced by stimulated human neutrophils. J. Clin. Invest. 84:1644-1649.
68. Jain, S., Saxena, D., Kumar, P. G., Koide, S. S., and Laloraya, M. 1999. Effect of estradiol and selected antiestrogens on pro- and antioxidant pathways in mammalian uterus. Contraception 60:111-118.
69. Jaiswal, M., LaRusso, N. F., Burgart, L. J., and Gores, G. J. 2000. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60:184-190.
70. Jansson, G. 1991. Oestrogen-induced enhancement of myeloperoxidase activity in human polymorphonuclear leukocytes - A possible cause of oxidative stress in inflammatory cells. Free Radical Res. Commun. 14:195-208.
71. Kalland, T. 1982. Long-term effects on the immune system of an early life exposure to diethylstilbestrol. In Environmental factors in human growth and development, eds. V. R. Hunt, M. K. Smith, and D. Worth, pp. 217-239. Cold spring Harbor, NY: Cold Spring Harbor Laboratory.
72. Kalland, T., and Holmdahl, R. 1984. Estrogen and immunity:Long-term consequences of the immune system by diethylstilbestrol. In Toxicity of hormones in prenatal life, ed. M. T. Nagasawa, pp. 114-125. Boca Raton, FL: CRC Press.
73. Kawamura, H., Nonogaki, T., Yoshikawa, K., Kimura, M., Ichihara, I., and Nakano, T. 2000. Morphological changes in mouse accessory sex glands following neonatal estrogen treatment. Anat. Anz. 182:269-274.
74. Kelly, P. M., Davison, R. S., Bliss, E., and McGee, J. O. 1988. Macrophages in human breast disease: a quantitative immunohistochemical study. Br. J. Cancer 57:174-177.
75. Kern, S., Robertson, S. A., Mau, V. J., and Maddocks, S. 1995. Cytokine secretion by macrophages in the rat testis. Biol. Reprod. 53:1407-1416.
76. Kincade, P. W., Medina, K. L., and Smithson, G. 1994. Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev. 137:119-134.
77. Klein, C. B. 1995. Are diethylstilbestrol and estradiol mutagenic? Proc. Am. Assoc. Cancer Res. 36:259.
78. Kong, L., Szaniszlo, Y., P., Albrecht, T., and Liehr, J. G. 2000. Frequency and molecular analysis of hprt mutations induced by estradiol in Chinese hamster V79 cells. Int. J. Oncol. 17:1141-1149.
79. Korach, K. S., Metzler, M., and McLachlan, J. A. 1978. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs. Proc. Natl. Acad. Sci. USA 75:468-471.
80. Korah, R. M., and and Humayun, M. Z. 1993. Mutagenic and recombinogenic effects of diethylstilbestrol quinone. Mutat. Res. 289:205-214.
81. Labrie, F. 1991. Intracrinology. Mol. Cell Endocrinol. 78:C113-C118.
82. Lahita, R. G. 1993. Sex hormones as immunomodulators of disease. Ann. NY Acad. Sci. 685:278-287.
83. Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S., Comstock, G. W., and Yager, J. D. 1997. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res. 57:5493-5497.
84. Law, D. J., Prasad, M. A., King, S. E., Spranger, K. D., Lee, Y. H., Fox. R. E., Collins, E. E., Gebuhr, T. C., Miller, D. E., and Petty, E. M. 1995. Localization of the human estrogen-responsive finger protein (EEP) gene (ZNF147) within a YAC contig containing the myeloperoxidase (MPO) gene. Genomics 28:361-363.
85. Leavitt, W. W., Evans, R. W., and Hendry, W. J. III. 1982. Etiology of DES-induced uterine tumors in the Syrian hamsters. In Hormones and cancer, ed. W. W. Leavitt, pp. 63-86. New York: Plenum.
86. Lee, A. H., Happerfield, L. C., Bobrow, L. G., and Millis, R. R. 1997. Angiogenesis and inflammation in invasive carcinoma of the breast. J. Clin. Pathol. 50:669-673.
87. Lee, A. H. S., Happerfield, L. C., Millis, R. R., and Bobrow, L. G. 1996. Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. Br. J Cancer 74:796-801.
88. Lee, A. J., Cai, M. X., Thomas, P. E., Conney, A. H., and Zhu, B. T. 2003. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 144:3382-3398.
89. Lee, Y. H., Howe, R. S., Sha, S. J., Teuscher, C., Sheehan, D.M., and Lyttle, C. R. 1989. Estrogen regulation of an eosinophilic chemotactic factor in the immature rat uterus. Endocrinology 125:3022-3028.
90. Li, B. Y., Mohanraj, D., Olson, M. C., Moradi, M., Twiggs, L., Carson, L. F. and Ramakrishnan, S., 1992. Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. Cancer Res. 52:2248-2252.
91. Li, Z. G., Danis, V. A., and Brooks, P. M. 1993. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin. Exp. Rheumatol. 11:157-162.
92. Liehr, J.G., and Roy, D. 1990. Free radical generation by redox cycling of estrogens. Free Radical Biol. Med. 8:415-423.
93. Lin, P.H., Nakamura, J., Yamaguchi, S., Asakura, S., and Swenberg, J. A. 2003. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis 24:1133-1141.
94. Mallery, S. R., Zeligs, B. J., Ramwell, P. W., and Bellani, J. A. 1986. Gender-related variations and interaction of human neutrophil cyclooxygenase and oxidative brust metabolites. J. Leukocyte Biol. 40:133-146.
95. Malins, D. C., and Haimanot, R. 1991. Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 51:5430-5432.
96. Malins, D. C., Holmes, E. H., Polissar, N. L., and Gunselman, S. J. 1993. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 71:3036-3043.
97. Maoz, H., Kaiser, N., Halimi, M., Barak, V., Haimovitz, A., Weinstein, D., Simon, A., Yagel, S., Biran, S., and Treves, A. J. 1985. The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J. Reprod. Immunol. 7:325-335.
98. Masuzawa, T., Miyauya, C., Onoe, Y., Kusano, K., Ohta, H., Nozawa, S., and Suda, T. 1994. Estrogen deficincy stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 94:1090-1097.
99. Matsui, A., Ikeda, T., Enomoto, K., Hosoda, K., Nakashima, H., Omae, K., Watanabe, M., Hibi, T., and Kitajima, M., 2000. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Lett. 151:87-95.
100. McLachlan, J. A., Newbold, R. R., and Bullock, B. 1975. Reproductive tract lesions in male mice exposed prenatally to diethylstilbestrol. Science 190:991-992.
101. Medina, K. L., Smithson, G., and Kincade, P. W. 1993. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med. 178:1507-1515.
102. Medina, K. L., Strasser, A., and Kincade, P. W. 2000. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95:2059-2067.
103. Mendis-Handagema, S. M., Risbridger, G. P., and de Kretser, D. M. 1987. Morphomertric analysis of the components of the neonatal and adult rat testis interstitium. Int. J. Androl. 10:525-534.
104. Miller, L., and Hunt, J. S. 1996. Sex steroid hormones and macrophage function. Life Sci. 59:1-14.
105. Miller, L., and Hunt, J. S. 1998. Regulation of TNF-α production in activated mouse macrophages by progesterone. J. Immunol. 160:5098-5104.
106. Miller, L. J., Kurtzman, S. H., Anderson, K., Wang, Y., Stankus, M., Renna, M., Lindquist, R., Barrows, G., and Kreutzer, D. L., 2000. Interleukin-1 family expression in human breast cancer: Interleukin-1 receptor antagonist. Cancer Invest. 18:293-302.
107. Mor, G., Yue, W., Santen, R. J., Gutierrez, L., Eliza, M., Berstein, L. M., Harada, N., Wang, J., Lysiak, J., Diano, S., and Naftolin, F. 1998. Macrophages, estrogen and the microenvironment of breast cancer. J. Steroid Biochem. Mol. Biol. 67:403-411.
108. Musarrat, J., Arezina-Wilson, J., and Wani, A. A. 1996. Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur. J. Cancer 32A:1209-1214.
109. Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., Kishimoto, T., and Taga, T. 1994. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 91:2285-2289.
110. Nash, M. A., Ferrandina, G., Gordinier, M., Loercher, A., and Freedman, R. S. 1999. The role of cytokines in both the normal and malignant ovary. Endocr. Relat. Cancer 6:93-107.
111. Nathan, I., Dizafaroglu, M., Bernstein, L., Junker, U., Le, C., Muegge, K., and Durham, S. 2000. Induction of oxidative DNA damage in U937 cells by TNF or anti-fas stimulation. Cytokine 12:881-887.
112. National Cancer Institute. 2003. Uses of hormones after menopause. http://cancer.gov/clinical trials digest-postmenopause-hormone-use
113. National Toxicology Program. 2002. Federal report on carcinogens. Fed. Reg. 67:77283-77285.
114. Ness, R. B., and Cottreau, C. 1999. Possible role of ovarian epithelial inflammation in ovarian cancer. JNCI 91:1459-1467.
115. Newbold, R. R. 1998. Influence of estrogenic agents on mammalian male reproductive tract development. In Reproductive and development toxicology, ed. K. S. Korach, pp. 531-551. New York: Marcel Dekker.
116. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. 1987. Testicular tumors in mice exposed in utero to diethylstilbestrol. J. Urol. 138:1446-1450.
117. Noller, K. L., Blair, P. B., O'Brien, P. C., Melton, L. J. 3d, Offord, J. R., Kaufman, R. H., and Colton, T. 1988. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil. Steril. 49:1080-1082.
118. Oberley, T. D., Allen, R. G., Schultz, J. L., and Lauchner, L. J. 1991. Antioxidant enzymes and steroid-induced proliferation of kidney tubular cells. Free Radical Biol. Med. 10:79-83.
119. Okamoto, M., Lee, C., and Oyasu, R. 1997. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 57:141-146.
120. Okuyama, R., Abo, T., Seki, S., Ohteki, T., Sugiura, K., Kusumi, A., and Kumagai, K. 1992. Estrogen administration activates extrathymic T cell differentiation in the liver. J. Exp. Med. 175:661-669.
121. Olsen, N. J., and Kovacs, W. J. 1996. Gonadal steroids and immunity. Endocr. Rev. 17:369-384.
122. Olson, S. H., Carlson, M. D., Ostrer, H., Harlap, S., Stone, A., Winters, M., and Ambrosone, C. B. 2004. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol. Oncol. 93:615-620.
123. Paavonen, T., Andersson, L. C., and Adlercreutz, H. 1981. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med. 154:1935-1945.
124. Polan, M. L., Daniele, A., and Kuo, A. 1988. Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil. Steril. 49:964-968.
125. Polan, M. L., Kuo, A., Loukines, J., and Bottomly, K. 1990. Cultured human luteal peripheral monocytes secrete increased levels of interleukin-1. J. Clin. Endocr. Metab. 70:480-484.
126. Qiu, Y., Ravi, L., and Kung, H. J. 1998. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393:83-85.
127. Quarmby, V. E., and Korach, K. S. 1984. The influence of 17 beta-estradiol on patterns of cell division in the uterus. Endocrinology 114:694-702.
128. Raburn, D. J., Coquelin, A., Reinhart, A. J., and Hutson, J. C. 1993. Regulation of the macrophage population in postnatal rat testis. J. Reprod. Immunol. 24:139-151.
129. Raftogianis, R., Creveling, C., Weinshilboum, R., and Weisz, J. 2000. Estrogen metabolism by conjugation. Natl. Cancer. Inst. Monogr. 27:113-124.
130. Reed, M. J., and Purohit, A. 1997. Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis. Endocr. Rev. 18:701-715.
131. Roberts, R. A. 1998. Transgenic rodent mutation/cancer bioassays: Cell cycle control, cell proliferation and apoptosis as modifiers of outcome. Mutat. Res. 398:189-195.
132. Robertson, S. A., Mayrhofer, G., and Seamark, R. F. 1996. Ovarian steroid hormones regulate granulocyte-macrophage colony-stimulating factor synthesis by uterine epithelial cells in the mouse. Biol. Reprod. 54:183-196.
133. Robinette, C. L. 1988. Sex-hormone-induced inflammation and fibromuscular proliferation in the rat lateral prostate. Prostate 12:271-286.
134. Ropper, R. J., Griffith, J. S., Lyttle, C. R., Doerge, R. W., McNabb, A. W., Broadbent, R. E., and Teuscher, C. 1999. Interacting quantitative trait loc control phenotypic variation in murine estradiol-regulated responses. Endocrinology 140:556-561.
135. Roy, D. 2000. Estrogen, immunoactivation and genomic instability. Int. J. Mol. Med. 6(suppl. 1):S66.
136. Roy, D., and Abul-Hajj, Y. 1997. Estrogen-nucleic acid adducts: Guanine is major site for interaction between 3,4-estrone quinone and Co III gene. Carcinogenesis 18:1247-1249.
137. Roy, D., and Cai, Q. 2002. Estrogen, immunoactivation, gene damages and development of breast, endometrial, ovarian, prostate and testicular cancers. Recent: Res Dev. Steroid Biochem. Mol. Biol. 3:1-32.
138. Roy, D., and Liehr, J. G. 1988. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters: Increased superoxide radical formation by redox cycling of estrogen. J. Biol. Chem. 263:3646-3651.
139. Roy, D., and Liehr, J. G., 1999. Estrogen, DNA damage and mutations. Mutat. Res. 424:107-115.
140. Roy, D., and Palangat, M., 1994. Active chromatin-associated protein tyrosine kinases: Their probable role in hormonal carcinogenesis. Proc. Int. Cancer Congress 56:633-637.
141. Roy, D., and Pathak, D. N. 1993. Modifications in the transcriptionally active chromatic low mobility group proteins by reactive metabolites of diethylstilbestrol. Biochem. Mol. Biol. Int. 31:923-934.
142. Roy, D., and Pathak, D. N. 1995. Covalent modifications in nuclear histone proteins by reactive metabolites of diethylstilbestrol. J. Environ. Health Toxicol. 44:447-457.
143. Roy, D., and Singh, K. P. 2004. Estrogen-induced genetic alterations and breast, endometrial, testicular and prostate cancers. Curr. Genom. 5:245-253.
144. Roy, D., and Thomas, R. D. 1994. Catalysis of the redox cycling reactions of estrogens by nuclear enzymes. Arch. Biochem. Biophys. 315:310-316.
145. Roy, D., Strobel, H. W., Coon, M. J., and Liehr, J. G. 1992. The oxidation of estrogens to estrogen quinones is catalyzed by betanaphthoflavone- inducible cytochrome P 450 IA1. Arch. Biochem. Biophys. 296:450-456.
146. Roy, D., Palangat, M., Chen, C. W., Thomas, R. T., Colerangle, J. C., Atkinson, A., and Yan, Z. J. 1997. Biochemical and molecular changes at the cellular levels in response to exposure of environmental estrogen-like chemicals. J. Toxicol. Environ. Health 49:101-129.
147. Roy, D., Colerangle, J., and Singh, K. P. 1998. Is exposure of environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability? Front. Biosci. 3d:913-921.
148. Roy, D., Parkash, J., and Narayan, S. 2004. Genetics and bioenergetics of mitochondria influencing the etiology and pharmacology of steroidal hormones. Curr. Pharmacogenomics 2:379-390.
149. Ruh, M. F., Bi, Y., D'Alonzo, R., and Bellone, C. J. 1998. Effect of estrogens on IL-1beta promoter activity. J. Steroid Biochem. Mol. Biol. 66:203-210.
150. Russo, J., Tahin, Q., Lareef, M. H., Hu, Y. F., and Russo, I. H. 2002. Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environ. Mol. Mutagen. 39:254-263.
151. Sakai, A., Miyata, N., and Takahashi, A. 1995. Initiating acitivity of quinone in the two stage transformation of BALB/3T3 cells. Carcinogenesis 16:477-481.
152. Santanam, N., Shern-Brewer, R., McClatchey, R., Castellano, P. Z., Murphy, A. A., Voelkel, S., and Parthasarathy, S. 1998. Estradiol as an antioxidant: Incompatible with its physiological concentrations and function. J. Lipid Res. 39:2111-2118.
153. Sarabia, S. F., Zhu, B. T., Kurosawa, T., Tohma, M., and Liehr, J. G. 1997. Mechanism of cytochrome P450-catalyzed aromatic hydroxylation of estrogens. Chem. Res. Toxicol. 10:767-771.
154. Sasaki, M., Kaneuchi, M., Sakuragi, N., and Dahiya, R. 2003. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res. 63:3101-3106.
155. Scambia, G., Testa, U., Panici, P. B., Martucci, R., Foti, E., Petrini, M., Amoroso, M., Masciullo, V., Peschle, C., and Mancuso, S. 1994. Interleukin-6 serum levels in patients with gynecological tumors. Int. J. Cancer 57:318-323.
156. Schwartz, E., Schafer, C, Bode, J. C., and Bode, C. 2000. Influence of the menstrual cycle on the LPS-induced cytokine response of monocytes. Cytokine 12:413-416.
157. Screpanti, I., Meco, D., Morrone, S., Gulino, A., Mathieson, B. J., and Frati, L. 1991. In vivo modulation of the distribution of thymocyte subsets: effects of estrogen on the expression of different T cell receptor V beta gene families in CD4-, CD8- thymocytes. Cell Immunol. 134:414-426.
158. 2+. Arch. Biochem. Biophys. 347:45-52.
159. Sharga, A., Felty, Q., and Roy, D. 2003. The influence of alcohol on estrogen-induced stimulation of cells in part occurs through reactive oxygen species. Proc. Am. Assoc. Cancer Res. 44:1200.
160. Simpson, E. R., Zhao, Y., Agarwal, V. R., Michael, M. D., Bulun, S. E., Hinshelwood, M. M,. Graham-Lorence, S., Sun, T., Fisher, C. R., Qin, K., and Mendelson, C. R. 1997. Aromatase expression in health and disease. Recent Prog. Horm. Res. 52:185-213.
161. Singh, K., López-Guerrero, J. A., Llombart-Bosch, A., and Roy, D. 2005. Estrogen-induced mutations and its role in the development of tumorigenesis, In Hormonal carcinogenesis IV, eds. J. J. Li, S. A. Li, and A. Llombart-Bosch, pp. 475-479. New York: Springer-Verlag.
162. Smith, B. J., and Holladay, S. D. 1997. Immune alterations in geriatric mice dosed subacutely with diethylstilbestrol (DES). J. Appl. Toxicol. 17:265-271.
163. Smithson, G., Couse, J. F., Lubahn, D. B., Korach, K. S., and Kincade, P. W. 1998. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J. Immunol. 161:27-34.
164. Stoker, T. E., Robinette, C. L., Britt, B. H., Laws, S. C., and Cooper, R. L. 1999a. Prepubertal exposure to compounds that increase prolactin secretion in the male rat: Effects on the adult prostate. Biol. Reprod. 61:1636-1643.
165. Stoker, T. E., Robinette, C. L., and Cooper, R. L. 1999b. Perinatal exposure to estrogenic compounds and the subsequent effects on the prostate of the adult rat: Evaluation of inflammation in the ventral and lateral lobes. Reprod. Toxicol. 13:463-472.
166. Tamura, K., Kumasaka, K., and Kogo, H. 1999. The expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and its regulation by ovarian steroids in rat uterine stromal cells. Jpn. J. Pharmacol. 79:257-262.
167. Terashima, I., Suzuki, N., and Shibutani, S. 2001. Mutagenic properties of estrogen quinone-derived DNA adducts in simian kidney cells. Biochemistry 40:166-172.
168. Thomas, R. D., and Roy, D. 2001. Stilbene estrogen produces higher levels of mitochondrial DNA adducts than nuclear DNA adducts in the target organ of cancer (liver) of male Sprague Dawley rats. Oncol. Rep. 8:1035-1038.
169. Thompson, P. A., and Ambrosone, C. 2000. Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. JNCI Monogr. 27:125-134.
170. Tibbetts, T. A., Conneely, O. M., and O'Malley, B. W. 1999. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol. Reprod. 60:1158-1165.
171. Venkat, S., Felty, Q., and Roy, D. 2003. Estrogen-induced stimulation of macrophages leading to the generation of reactive oxygen species in the target organ of cancer. Toxicologist 67:235.
172. Verthelyi, D. I., and Ahmed, S. A. 1988. Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell Immunol. 189:125-134.
173. Vingerhoets, A. J., Assies, J., Goodkin, K., Van Heck, G. L., and Bekker, M. H. 1988. Prenatal diethylstilbestrol exposure and self-reported immune-related diseases. Eur. J. Obstet. Gynecol. Reprod. Biol. 77:205-209.
174. Walker, C., Ahmed, S. A., Brown, T., Ho, S. M., Hodges, L., Lucier, G., Russo, J., Weigel, N., Weise, T., and Vandenbergh, J. 1999. Species, interindividual, and tissue specificity in endocrine signaling. Environ. Health Perspect. 107(suppl. 4):619-624.
175. Wang, J., Wreford, N. G., Lan, H. Y., Atkins, R., and Hedger, M. P. 1994. Leukocyte populations of the adult rat testis following removal of the Leydig cells by treatment with ethane dimethane sulfonate and subcutaneous testosterone implants. Biol. Reprod. 51:551-561.
176. Watson, C. S., Campbell, C. H., and Gametchu B. 1999. Membrane estrogen receptors on rat pituitary tumor cells immunoidentification and responses to estradiols and xenoestrogens. Exp. Physiol. 84:1013-1022.
177. Ways, S. C., Mortola, J. F., Zvaifler, N. J., Weiss, R. J., and Yen, S. S. 1987. Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero. Fertil. Steril. 48:193-197.
178. Wendell, D. L., and Gorski, J. 1997. Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat. Mamm. Genome 8:823-829.
179. Weitzman, S. A., and Stossel, T. P. 1981. Mutation caused by human phagocytes. Science 212:546-547.
180. Wingard, D. L., and Turiel, J. 1988. Long-term effects of exposure to diethylstilbestrol. West. J. Med. 149:551-554.
181. Yamada, M., Yoshida, M., and Hashinaka, K. 1993. Identification of transcriptional cis-elements in introns 7 and 9 of the myeloperoxidase gene. J. Biol. Chem. 268:13479-13485.
182. Yan, Z. J., and and Roy, D. 1995. Mutations of DNA Polymerase beta mRNA in stilbene estrogen-induced kidney tumors. Biochem. Mol. Biol. Int. 37:175-183.
183. Yasui, M., Matsui, S., Laxmi, Y. R., Suzuki, N., Kim, S. Y., Shibutani, S., Matsuda, T. 2003. Mutagenic events induced by 4-hydroxyequilin in supF shuttle vector plasmid propagated in human cells. Carcinogenesis 24:911-917.
184. Yoshida, Y., Nakamura, Y., Sugino, N., Shimamura, K., Ono, M., and Kato, H. 1996. Changes in interleukin-1 production of peritoneal macrophages during estrous cycle in golden hamsters. Endocr. J. 43:151-156.
185. Yoshie, Y., and Ohshima, H. 1998. Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: Implications for hormonal carcinogenesis. Free Radical Biol. Med. 24:341-348.
186. Zhang, F., Chen, Y., Pisha, E., Shen, L., Xiong, Y., van Breemen, R. B., and Bolton, J. 1999. The major metabolite of equilin, 4-hydroxyequilin, autoxidizes to an o-quinone which isomerizes to the potent cytotoxin 4-hydroxyequilenin-o-quinone. Chem. Res. Toxicol. 12:204-213.
187. Zhang, F., Swanson, S. M., van Breemen, R. B., Liu, X., Yang, Y., Gu, C., and Bolton, J. L. 2001. Equine estrogen metabolite 4-hydroxyequilenin induces DNA damage in the rat mammary tissues: Formation of single-strand breaks, apurinic sites, stable adducts, and oxidized bases. Chem. Res. Toxicol. 14:1654-1659.
188. Zhao, Y., Nichols, J. E., Valdez, R., Mendelson, C. R., and Simpson, E. R. 1996. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter. Mol. Endocrinol. 10:1350-1357.
189. Zheng, W., Xie, D., Cerhan, J. R., Sellers, T. A., Wen, W., and Folsom, A. R. 2001. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 10: 89-94.
190. Zuckman, S. H., Ahmed, S. E., Bryan-Poole, N., Evans, G. F., Short, I., and Glassbrook, A. L. 1996. Estriol: A potent regulator of TNF and IL-6 expression in a murine model of endotoxemia. Inflammation 20:581-597.
191. Zuk, J. A., and Walker, R. A. 1987. Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J. Pathol. 152:275-285.